Medtech Talk

By HealthegyBusiness Investing

Favorites
39
Followers
Typical duration
57 min
per episode

Based on Podcast App listening data

Medtech Talk episodes

August 26, 2016 Everything Medtech Companies Need to Know About Making Friends (& Closing Deals) in China
Chen Yu, MD, managing director of Vivo Capital, has built a career finding the right deals at the right time in the US and China. Hear what US companies can do to take advantage of potential Pan Pacific opportunities.
31 min
August 19, 2016 Where Are Series A Dollars Coming From? What Areas Are Ripe for M&A? You May Be Surprised
Data guru Jon Norris, managing director at Silicon Valley Bank, reviews his first-half numbers for ophthalmology and life sciences. Norris’ first-half numbers for Medtech start-ups show some surprising sources of strength for the sector.
18 min
August 11, 2016 ReVision CEO John Kilcoyne Says the Company is Ready to Build a New Medtech Market in Ophthalmology
ReVision Optics built it – a corneal inlay capable of correcting presbyopia. The FDA approved it sooner than expected. Now the company needs to build it into a successful private-pay business.
28 min
August 04, 2016 What Will Carl Zeiss Meditec’s New Ophthalmology Unit Look Like? We Ask Jim Mazzo.
Meet the newest Master of the Industry. Jim Mazzo, who has led divisions, spin-outs, and start-ups, now leads what looks to be a new leader in ophthalmology. Hear how Mazzo views this new opportunity for Zeiss and himself.
26 min
July 27, 2016 From an "Ah, Ha!" Moment to Restoring Sight – Innovator Mark Humayun, MD, on What Drives Innovation
Over two decades ago, Mark Humayun – who will co-chair our upcoming OIS@ASRS meeting in San Francisco – helped launch a “moonshot” that would eventually restore vision for retinitis pigmentosa patients. In this podcast we discuss what drives him and what’s next for ophthalmology.
25 min
July 21, 2016 Cartiva’s FDA Win for Approval of First Synthetic Cartilage Signals Change for Orthopedics
Cartiva secured an historic win when the FDA approved its synthetic cartilage. CEO Tim Patrick explains what it took to get the approval and how the company will sell going forward.
34 min
July 14, 2016 Perfecting the Fast-Follower Strategy – How Blue Belt Built and Sold a Successful Robotics Business
Eric Timko, the former CEO of Blue Belt, shares how the company used MAKO’s wake to build a market for its surgical robot and sell the business to Smith & Nephew. Timko explains the company’s fast-follower strategy and shares what he’s looking to do next.
30 min
July 07, 2016 How Do You Build a Start-Up into a $600 Million Exit? We Ask Matt Likens, Former CEO of Ulthera
The board at Ulthera, an aesthetics device company, faced an attractive dilemma. Take the company public? Or accept a lucrative buyout? Hear from the CEO how the company’s culture and approach led to that favorable outcome.
41 min
June 30, 2016 Gilde Healthcare’s Geoff Pardo on Why European LPs & VCs See Opportunity in the US Medtech Market
Gilde Healthcare Partner Geoff Pardo shares how the firm will invest its new $250 million in health care companies, including Medtech.
36 min
June 23, 2016 Allen Partners’ Julie Allen on How New Leaders Can Find Success in Today’s Evolving Medtech Sector
Julie Allen, principal of Allen Partners, shares insights on how Medtech executives must work to find the right fit and how companies can build their best team.
41 min